Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,521 papers from all fields of science
Search
Sign In
Create Free Account
HP 029
Known as:
HP-029
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
velnacrine
velnacrine maleate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
HP-029-1 SM大腸癌の術後再発のリスク因子(大腸(SM大腸癌治療2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
稲垣 大輔
,
金澤 周
,
+4 authors
武宮 省治
2009
Corpus ID: 173518237
2009
2009
HP-029-2 大腸pSM癌の術後再発例の検討(大腸(SM大腸癌治療2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
飯田 修史
,
博俊 長谷川
,
+5 authors
北川 雄光
2009
Corpus ID: 173571499
2009
2009
HP-029-6 EMR後sm大腸癌の検討 : 追加切除を減少させるには(大腸(SM大腸癌治療2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
副島 剛
,
佐野 秀一
,
+5 authors
三澤 一仁
2009
Corpus ID: 173328668
1993
1993
EEG-Mapping bei Alzheimer Patienten unter Behandlung mit Velnacrine (HP-029)
R. Horn
,
S. Kasper
,
V. Eichert
,
H. Möller
1993
Corpus ID: 78651055
Bei Patienten mit einer Demenz vom Alzheimer Typ werden typische EEG Befunde beschrieben [1], die sich unter der Gabe von…
Expand
1990
1990
Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4‐Tetrahydro‐9‐aminoacridin‐1‐oL‐maleate (HP 029) in Alzheimer's Disease: Preliminary Findings
N. Cutler
,
M. Murphy
,
R. Nash
,
P. Prior
,
Diane M. Luna
Journal of clinical pharmacology
1990
Corpus ID: 10941409
HP 029 (1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐oL‐maleate), an oral anticholinesterase, enhances memory in rodents and may be useful…
Expand
1990
1990
Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease
S. Puri
,
I. Ho
,
R. Hsu
,
H. Lassman
Journal of clinical pharmacology
1990
Corpus ID: 20177760
The pharmacokinetics, safety, and tolerance of 1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐ol‐ maleate (HP 029) a potential therapeutic…
Expand
1990
1990
Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.
K. Natori
,
Y. Okazaki
,
T. Irie
,
J. Katsube
Japanese Journal of Pharmacology
1990
Corpus ID: 23994170
The effects of the compound SM-10888 (9-amino-8-fluoro-1,2,3,4-tetrahydro-2,4-methanoacridine citrate) in a number of…
Expand
1990
1990
Effect of a novel CNS-selective cholinesterase inhibitor, SM-10888, on habituation and passive avoidance responses in mice.
Y. Okazaki
,
K. Natori
,
T. Irie
,
J. Katsube
Japanese Journal of Pharmacology
1990
Corpus ID: 23915350
The effects of the tacrine (THA) derivative SM-10888 (9-amino-8-fluoro-1,2,3,4-tetrahydro-2,4-methanoacridine citrate) on…
Expand
Highly Cited
1989
Highly Cited
1989
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
G. Shutske
,
F. Pierrat
,
+6 authors
K. Davis
Journal of Medicinal Chemistry
1989
Corpus ID: 8304688
The synthesis of a series of 9-amino-1,2,3,4-tetrahydroacridin-1-ols is reported. These compounds are related to 1,2,3,4…
Expand
1989
1989
The Effect of Food on the Bioavailability of Velnacrine (HP 029) in Healthy Elderly Men: A Potential Alzheimer Agent
S. Puri
,
R. Hsu
,
I. Ho
,
H. Lassman
Journal of clinical pharmacology
1989
Corpus ID: 41854156
Velnacrine (HP 029; 1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐ol‐maleate) is an investigational drug being studied in patients with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE